Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.34
-0.15-2.00%
al cierre: -
$7.35
0.010000.14%
After hour: 7:50 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Teladoc Health Inc ha un obiettivo di prezzo di consenso pari a $15.13, stabilito in base alle ultime valutazioni degli analisti di 30. Le ultime 3 valutazioni degli analisti sono state rilasciate da Mizuho, Evercore ISI Group y B of A Securities il julio 25, 2025, julio 9, 2025 y mayo 28, 2025. Con un obiettivo di prezzo medio di $8.33 tra le Mizuho, Evercore ISI Group y B of A Securities, c'è un implicito 13.38% upside per Teladoc Health Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Mizuho
Evercore ISI Group
B of A Securities
Truist Securities
Wells Fargo
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Teladoc Health
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/25/2025 | 36.05% | Mizuho | → $10 | Initiates | → Neutral | |||
07/09/2025 | 8.84% | Evercore ISI Group | $7 → $8 | Maintains | In-Line | |||
05/28/2025 | -4.76% | B of A Securities | $8 → $7 | Maintains | Neutral | |||
05/27/2025 | 22.45% | Truist Securities | $10 → $9 | Maintains | Hold | |||
05/08/2025 | 8.84% | Wells Fargo | $10 → $8 | Maintains | Equal-Weight | |||
05/01/2025 | 63.27% | Canaccord Genuity | $14 → $12 | Maintains | Buy | |||
05/01/2025 | 36.05% | Goldman Sachs | $13 → $10 | Maintains | Buy | |||
05/01/2025 | 8.84% | Stifel | $9 → $8 | Maintains | Hold | |||
05/01/2025 | -4.76% | Evercore ISI Group | $8 → $7 | Maintains | In-Line | |||
05/01/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
04/25/2025 | 19.05% | Citigroup | $11 → $8.75 | Maintains | Neutral | |||
04/21/2025 | 8.84% | Jefferies | $10 → $8 | Maintains | Hold | |||
04/11/2025 | 8.84% | B of A Securities | $9.5 → $8 | Maintains | Neutral | |||
03/03/2025 | 76.87% | Goldman Sachs | $16 → $13 | Maintains | Buy | |||
02/27/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
02/27/2025 | 63.27% | Piper Sandler | $13 → $12 | Maintains | Overweight | |||
02/18/2025 | 117.69% | Goldman Sachs | $14 → $16 | Maintains | Buy | |||
02/12/2025 | 83.67% | B of A Securities | $11.5 → $13.5 | Maintains | Neutral | |||
02/06/2025 | 56.46% | B of A Securities | $10.5 → $11.5 | Maintains | Neutral | |||
01/24/2025 | 63.27% | RBC Capital | $11 → $12 | Maintains | Outperform | |||
01/24/2025 | 63.27% | Oppenheimer | $14 → $12 | Maintains | Outperform | |||
12/04/2024 | 76.87% | Piper Sandler | $11 → $13 | Reiterates | Overweight → Overweight | |||
11/15/2024 | 90.48% | Goldman Sachs | → $14 | Initiates | → Buy | |||
11/01/2024 | 63.27% | Deutsche Bank | $10 → $12 | Maintains | Hold | |||
10/31/2024 | 63.27% | Barclays | $10 → $12 | Maintains | Overweight | |||
10/31/2024 | 8.84% | TD Cowen | $9 → $8 | Maintains | Hold | |||
10/09/2024 | 36.05% | RBC Capital | $9 → $10 | Maintains | Outperform | |||
10/08/2024 | 22.45% | Evercore ISI Group | $8 → $9 | Maintains | In-Line | |||
09/17/2024 | 36.05% | Jefferies | $8 → $10 | Maintains | Hold | |||
08/26/2024 | 22.45% | JP Morgan | $16 → $9 | Maintains | Neutral | |||
08/20/2024 | 36.05% | Cantor Fitzgerald | $10 → $10 | Reiterates | Overweight → Overweight | |||
08/06/2024 | 36.05% | Piper Sandler | $25 → $10 | Maintains | Overweight | |||
08/02/2024 | 36.05% | Deutsche Bank | $15 → $10 | Maintains | Hold | |||
08/02/2024 | 36.05% | Truist Securities | $15 → $10 | Maintains | Hold | |||
08/01/2024 | — | Needham | — | Reiterates | → Hold | |||
08/01/2024 | 22.45% | TD Cowen | $15 → $9 | Maintains | Hold | |||
08/01/2024 | 22.45% | RBC Capital | $18 → $9 | Maintains | Outperform | |||
08/01/2024 | 36.05% | Barclays | $20 → $10 | Maintains | Overweight | |||
08/01/2024 | 22.45% | Stifel | $16 → $9 | Maintains | Hold | |||
08/01/2024 | 8.84% | DA Davidson | $12 → $8 | Maintains | Neutral | |||
08/01/2024 | 131.29% | Canaccord Genuity | $25 → $17 | Maintains | Buy | |||
08/01/2024 | 131.29% | Oppenheimer | $21 → $17 | Maintains | Outperform | |||
07/09/2024 | 36.05% | Evercore ISI Group | $14 → $10 | Maintains | In-Line | |||
05/21/2024 | 117.69% | JP Morgan | $19 → $16 | Maintains | Neutral | |||
05/20/2024 | 90.48% | Jefferies | $16 → $14 | Maintains | Hold | |||
05/14/2024 | 83.67% | B of A Securities | $16.5 → $13.5 | Maintains | Neutral | |||
04/29/2024 | 104.08% | Wells Fargo | $17 → $15 | Maintains | Equal-Weight | |||
04/26/2024 | 185.71% | Oppenheimer | $26 → $21 | Maintains | Outperform | |||
04/26/2024 | 104.08% | TD Cowen | $16 → $15 | Maintains | Hold | |||
04/26/2024 | 90.48% | Evercore ISI Group | — | $15 → $14 | Maintains | In-Line | ||
04/26/2024 | 144.9% | RBC Capital | $25 → $18 | Maintains | Outperform | |||
04/26/2024 | 117.69% | Stifel | $21 → $16 | Maintains | Hold | |||
04/26/2024 | 172.11% | Barclays | $25 → $20 | Maintains | Overweight | |||
04/26/2024 | 240.14% | Canaccord Genuity | $28 → $25 | Maintains | Buy | |||
04/26/2024 | — | Needham | — | Reiterates | → Hold | |||
04/05/2024 | — | Needham | — | Reiterates | → Hold | |||
03/06/2024 | 131.29% | Truist Securities | $23 → $17 | Maintains | Hold | |||
02/29/2024 | 199.32% | Cantor Fitzgerald | → $22 | Initiates | → Overweight | |||
02/26/2024 | 131.29% | Leerink Partners | → $17 | Initiates | → Market Perform | |||
02/21/2024 | 144.9% | DA Davidson | $22 → $18 | Maintains | Neutral | |||
02/21/2024 | 158.5% | Citigroup | $21 → $19 | Maintains | Neutral | |||
02/21/2024 | 240.14% | RBC Capital | $30 → $25 | Maintains | Outperform | |||
02/21/2024 | 240.14% | Barclays | $26 → $25 | Maintains | Overweight | |||
02/21/2024 | 240.14% | Piper Sandler | $30 → $25 | Maintains | Overweight | |||
02/21/2024 | 280.95% | Canaccord Genuity | $34 → $28 | Maintains | Buy | |||
11/17/2023 | 158.5% | JP Morgan | $33 → $19 | Maintains | Neutral | |||
10/25/2023 | 308.16% | RBC Capital | $35 → $30 | Maintains | Outperform | |||
10/25/2023 | 253.74% | Oppenheimer | $35 → $26 | Maintains | Outperform | |||
10/23/2023 | 185.71% | Citigroup | $29 → $21 | Maintains | Neutral | |||
10/20/2023 | 185.71% | Citigroup | $29 → $21 | Maintains | Neutral | |||
09/25/2023 | 280.95% | Truist Securities | → $28 | Reiterates | Hold → Hold | |||
07/26/2023 | 280.95% | Stephens & Co. | → $28 | Reiterates | Equal-Weight → Equal-Weight | |||
07/26/2023 | 376.19% | RBC Capital | → $35 | Reiterates | Outperform → Outperform | |||
07/26/2023 | 294.56% | Citigroup | $31 → $29 | Maintains | Neutral | |||
07/26/2023 | 267.35% | Credit Suisse | → $27 | Reiterates | Neutral → Neutral | |||
04/28/2023 | 294.56% | Deutsche Bank | $27 → $29 | Maintains | Hold | |||
04/27/2023 | 321.77% | Citigroup | $30 → $31 | Maintains | Neutral | |||
04/27/2023 | 376.19% | RBC Capital | → $35 | Reiterates | → Outperform | |||
04/27/2023 | 267.35% | Credit Suisse | → $27 | Reiterates | → Neutral | |||
04/27/2023 | 294.56% | Barclays | $28 → $29 | Maintains | Equal-Weight | |||
04/12/2023 | 240.14% | Stephens & Co. | → $25 | Initiates | → Equal-Weight | |||
03/10/2023 | 267.35% | Credit Suisse | $30 → $27 | Maintains | Neutral | |||
03/06/2023 | 389.8% | Canaccord Genuity | $40 → $36 | Maintains | Buy | |||
03/06/2023 | 212.93% | Wells Fargo | $28 → $23 | Maintains | Equal-Weight | |||
02/28/2023 | 308.16% | Citigroup | $33 → $30 | Maintains | Neutral | |||
02/27/2023 | 267.35% | Deutsche Bank | $31 → $27 | Maintains | Hold | |||
02/27/2023 | 348.98% | JP Morgan | $35 → $33 | Maintains | Neutral | |||
02/23/2023 | 376.19% | Oppenheimer | $37 → $35 | Maintains | Outperform | |||
02/23/2023 | 376.19% | RBC Capital | → $35 | Reiterates | → Outperform | |||
02/23/2023 | 362.59% | SVB Leerink | → $34 | Upgrade | Market Perform → Outperform | |||
01/19/2023 | 403.4% | Oppenheimer | $45 → $37 | Maintains | Outperform | |||
01/18/2023 | 280.95% | Barclays | $32 → $28 | Maintains | Equal-Weight | |||
12/13/2022 | 348.98% | Citigroup | $36 → $33 | Maintains | Neutral | |||
10/31/2022 | 308.16% | Credit Suisse | $35 → $30 | Maintains | Neutral | |||
10/27/2022 | 389.8% | Citigroup | $38 → $36 | Maintains | Neutral | |||
10/27/2022 | 335.37% | Barclays | $33 → $32 | Maintains | Equal-Weight | |||
10/25/2022 | 444.22% | DA Davidson | $45 → $40 | Maintains | Buy | |||
10/24/2022 | — | Guggenheim | — | Upgrade | Sell → Neutral | |||
10/21/2022 | 294.56% | Truist Securities | $35 → $29 | Maintains | Hold | |||
10/11/2022 | 348.98% | Barclays | $40 → $33 | Maintains | Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Teladoc Health (TDOC)?
El último precio objetivo de Teladoc Health (NYSE:TDOC) fue comunicado por Mizuho el julio 25, 2025. La firma de analistas fijó un precio objetivo para $10.00 que espera TDOC a rise dentro de 12 meses (un posible 36.05% upside). 30 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Teladoc Health (TDOC)?
La última calificación de analistas para Teladoc Health (NYSE:TDOC) fue proporcionada por Mizuho, y Teladoc Health iniciado su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Teladoc Health (TDOC)?
La última revisión al alza de Teladoc Health Inc se produjo en febrero 23, 2023, cuando SVB Leerink elevó su precio objetivo a $34. SVB Leerink anteriormente tenía a market perform para Teladoc Health Inc.
¿Cuándo fue la última revisión a la baja de Teladoc Health (TDOC)?
No hay una última revisión a la baja para Teladoc Health.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Teladoc Health (TDOC)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Teladoc Health, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Teladoc Health se registró el julio 25, 2025, por lo que la próxima calificación estará disponible en torno al julio 25, 2026.
¿Es correcta la calificación de los analistas sobre Teladoc Health (TDOC)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Teladoc Health (TDOC) fue un iniciado con un precio objetivo de $0.00 a $10.00. El precio actual al que cotiza Teladoc Health (TDOC) es de $7.35, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.